Could a longer ER stay help more people start opioid addiction treatment?
NCT ID NCT05064826
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study compares standard emergency department care to an extended observation period for people with opioid use disorder. Participants are randomly assigned to either leave after a regular ED visit or stay longer in an observation unit to receive their first dose of buprenorphine and get a warm handoff to follow-up care. The goal is to see if the extended approach increases the number of people who start medication and stay engaged in treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
buprenorphine (BUP)
What this could lead to
If successful, this could show that keeping people in the ED for observation helps them start addiction medication and connect to follow-up care more reliably.
What could go wrong
This is a mid-stage trial with 170 participants, so results may not apply to all settings. The main focus is on starting treatment, not long-term outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bellevue
New York, New York, 10016, United States
-
NYULH-Brooklyn
Brooklyn, New York, 11220, United States
-
NYULH-Tisch
New York, New York, 10016, United States
-
Northwell Health - Long Island Jewish Medical Center
New Hyde Park, New York, 11040, United States
-
Northwell Health - Staten Island University Hospital
Staten Island, New York, 10305, United States
-
Rutgers University-University Hospital
Newark, New Jersey, 07103, United States